Clinical Trials
Allergies & Asthma
Benaroya Research Institute and Virginia Mason Medical Center Asthma and Allergy Department are working together to study asthma and immune responses to allergens.
Clinical Research Studies in Allergies
Studies labeled as “Enrolling” are actively recruiting new participants while studies labeled as “Closed to Enrollment” are still active but no longer seeking new participants.
Please email the Clinical Trials Unit or call (206) 287-6260 for more information.
- A Phase 2, Open Label Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper Sponsored Chronic Urticaria Trials.
Learn more at Clinicaltrials.gov
Principal Investigator: Rahool Davé, MD
Status: Enrolling- A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy with DBV712 250 μg in 4-7-year-old Children with Peanut Allergy (VITESSE)
Learn more at Clinicaltrials.gov
Principal Investigator: Rahool Davé, MD
Status: Closed to Enrollment- A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Treatment with Omalizumab
Learn more at Clinicaltrials.gov
Principal Investigator: Rahool Davé, MD
Status: Closed to Enrollment
